financetom
Personal Finance
financetom
/
Personal Finance
/
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pentair Plc
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Research Alert: CFRA Keeps Buy Opinion On Shares Of Pentair Plc
Oct 21, 2025 11:18 PM

01:45 AM EDT, 10/22/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We reaffirm our Buy recommendation on PNR shares following Q3 results and raise our 12-month target to $125 from $120, valuing shares at 23x our 2026 EPS of $5.43 (up from $5.35; 2025 EPS outlook lifted to $4.89 from $4.85), above PNR's historical average. Organic sales expansion remained broad-based during the quarter, with core growth being led by its Pools performance. Tariff impacts were managed via pricing actions and supply chain actions - PNR is working to reduce supply chain exposure to China, which we view as a prudent move to reduce sourcing risks. Looking ahead to 2026, management indicated that pricing carryover will serve as a tailwind for both sales and bottom-line results. We view anticipated rate cuts as a potential catalyst for relevant market recoveries given PNR's exposure to construction spending. We are bullish on PNR's ongoing portfolio buildout via M&A, with a balance sheet that we see supporting accretive deals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Research Alert: CFRA Keeps Hold Opinion On Adss Of Novo Nordisk
Jun 13, 2025
04:35 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We revised our target price to USD81 (up from USD64), which implies 19.6x our 2025 EPADS. This is at a discount to its historical forward P/E average of 30x-32x, justified...
Research Alert: CFRA Lowers Opinion On Shares Of Shell To Sell From Hold
Research Alert: CFRA Lowers Opinion On Shares Of Shell To Sell From Hold
Jun 13, 2025
03:40 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We maintain our 12-month target price for Shell at USD59 based on 2025 P/E of 9.2x, which reflects 0.5 standard deviation below its 10-year average of 11.6x. Our EPS forecasts...
Research Alert: CFRA Raises Opinion On The Energy Sector To Marketweight From Underweight
Research Alert: CFRA Raises Opinion On The Energy Sector To Marketweight From Underweight
Jun 13, 2025
09:20 AM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: In light of the Israeli attack on Iran's nuclear facilities, we recommend upgrading the investment outlook for the Energy Sector. If the military action expands to include Iran's oil facilities,...
Research Alert: CFRA Lowers Opinion On Health Care To Underweight From Marketweight
Research Alert: CFRA Lowers Opinion On Health Care To Underweight From Marketweight
Jun 13, 2025
12:50 PM EDT, 06/13/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We continue to see elevated policy uncertainties ahead in health care with the on-going Section 232 investigation to assess the impact of pharmaceuticals and API imports on national security. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved